TruScreen Group Limited (NZE:TRU)

Market Cap	13.45M
Revenue (ttm)	2.07M
Net Income (ttm)	-2.24M
Shares Out	747.33M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	232,261
Average Volume	299,362
Open	0.0190
Previous Close	0.0180
Day's Range	0.0170 - 0.0190
52-Week Range	0.0160 - 0.0370
Beta	-0.32
RSI	52.49
Earnings Date	Nov 28, 2025

About TruScreen Group

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. TruScreen Group Limited was incorporated in...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Country: New Zealand
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: TRU

Financial Performance

In 2024, TruScreen Group's revenue was 2.07 million, a decrease of -20.28% compared to the previous year's 2.60 million. Losses were -2.24 million, 9.41% more than in 2023.